Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Abiomed Inc Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$310.19 - $376.2 $387,427 - $469,873	-1,249 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$262.71 - $351.17 $11,296 - $15,100	-43 Reduced 3.33%	1,249 $390,000
Q1 2021 Apr 20, 2021	BUY	$285.92 - $355.13 $369,408 - $458,827	1,292 New	1,292 $412,000
Q3 2020 Oct 20, 2020	SELL	$255.22 - $317.0 $185,544 - $230,459	-727 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$141.4 - $257.09 $102,797 - $186,904	727 New	727 $176,000
Q1 2020 Apr 23, 2020	SELL	$130.51 - $196.01 $87,311 - $131,130	-669 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$159.31 - $223.54 $357,969 - $502,294	-2,247 Reduced 77.06%	669 $112,000
Q3 2019 Oct 29, 2019	BUY	$175.89 - $279.23 $217,400 - $345,128	1,236 Added 73.57%	2,916 $511,000
Q1 2019 Apr 29, 2019	BUY	$276.39 - $362.25 $464,335 - $608,580	1,680 New	1,680 $477,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account